asa glp-1 agonist guidelines Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 GLP-1 medications safe to continue

Emerging evidence suggests that allulose may exert GLP-1-like effects through multiple pathways: Incretin hormone stimulation : Studies demonstrate that allulose consumption stimulates the release of GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) from intestinal L-cells and K-cells, respectively

Coverage depends on the plan, formulary, FDA indication on the prescription, and prior authorization criteria

Effects of onceweekly exenatide on cardiovascular outcomes in type 2 diabetes

Targeted estrogen delivery reverses the metabolic syndrome

& Heagerty, A

The Evaluate report highlights Pfizers exposure to upcoming patent expirations, especially for notable drugs like the blood thinner Eliquis (apixaban) and breast cancer drug Ibrance (palbociclib) in 2027/2028